KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30

KESTRA MEDICAL TECHNOLOGIES, LTD.

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026

$29.37+2.13 (+7.82%)

Close on Oct 19, 2026

Community

Notes and questions about Kestra Medical Technologies from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Kestra Medical Technologies's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is KMTS.

Revenue growth60.7% · median 12.0%

Gross margin53.9% · median 81.5%

Operating margin-134.5% · median -42.6%

Net margin-140.4% · median -51.5%

Advertisement
300 × 250